DB

David Brookes

Anatara Lifesciences Ltd | Executive Chairman, Executive Director
Dr. Brookes has extensive experience in the health and biotechnology industries, first becoming involved in the biotechnology sector in the late 1990's as an analyst. Dr. Brookes has since held Board positions in a number of ASX listed biotechnology companies. Dr. Brookes maintains roles as a clinician and as a biotechnology industry consultant. He is a Member of the audit and risk management committee Member of the remuneration and nominations committee.

Companies and Roles

Company
Title
Tenure
Since
ANR
Anatara Lifesciences Ltd
  • Executive Chairman
  • Executive Director
1yrs, 9mthJun 2022
TD1
TALI Digital Limited
  • Non-Executive Director
3yrs, 9mthJun 2020
DLM
Dominion Minerals Limited
  • Non-Executive Director
  • Non-Executive Chairman
5yrsApr 2019
ILA
Island Pharmaceuticals Limited
  • Non-Executive Director
3yrs, 6mthOct 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ILA
Island Pharmaceuticals Limited
26/03/24N/A140,000440,000N/A
ANR
Anatara Lifesciences Ltd
11/12/231,240,0003,290,0021,832,143N/A
TD1
TALI Digital Limited
30/06/23457,14421,185,71618,000,000N/A
DLM
Dominion Minerals Limited
31/03/23N/A4,901,250500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ILA
Island Pharmaceuticals Limited
26/03/24
Issued
40,000$0.060$2,400Rights issue
ILA
Island Pharmaceuticals Limited
26/03/24
Issued
40,000$0.060$2,400Rights issue
ANR
Anatara Lifesciences Ltd
11/12/23
Issued
750,000$0.022$16,500Rights issue
ANR
Anatara Lifesciences Ltd
11/12/23
Issued
750,000$0.022$16,500Rights issue
ANR
Anatara Lifesciences Ltd
08/12/23
Issued
140,000$0.022$3,080Rights issue